Evidence map›Paper›PMID 38386577›Full record

ReviewIEEE reviews in biomedical engineering2025

Glucose Fuel Cells: Electricity From Blood Sugar.

Robert G Gloeb-McDonald, Gene Y Fridman

Abstract readReview
In one paragraph

Review in IEEE reviews in biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robert G Gloeb-McDonald
Gene Y Fridman

Funding

Safe Direct Current Stimulator (SDCS) technology for blocking chronicperipheral painR01NS110893 · NINDS · JOHNS HOPKINS UNIVERSITY · PI FRIDMAN, GENE YEVGENY · 2020 to 2023
$2.2M
NINDS NIH HHS R01 NS110893
6 · The paper itself

Abstract

Harvesting energy from the human body is an area of growing interest. While several techniques have been explored, the focus in the field is converging on using Glucose Fuel Cells (GFCs) that use glucose oxidation reactions at an anode and oxygen reduction reactions (ORRs) at a cathode to create a voltage gradient that can be stored as power. To facilitate these reactions, catalysts are immobilized at an anode and cathode that result in electrochemistry that typically produces two electrons, a water molecule, and gluconic acid. There are two competing classes of these catalysts: enzymes, which use organic proteins, and abiotic options, which use reactive metals. Enzymatic catalysts show better specificity towards glucose, whereas abiotic options show superior operational stability. The most advanced enzymatic test showed a maximum power density of 119 µW/cm2 and an efficiency loss of 4% over 15 hours of operation. The best abiotic experiment resulted in 43 µW/cm2 and exhibited no signs of performance loss after 140 hours. Given the range of existing implantable devices' power budget from 10 µW to 100 mW and expected operational duration of 10 years or more, GFCs hold promise, but considerable advances need to be made to translate this technology to practical applications.

Indexed as

Bioelectric Energy SourcesBlood GlucoseGlucoseElectricityElectrodesHumansOxidation-ReductionBlood GlucoseGlucose

Identifiers

PMID38386577
PMCPMC12315024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.